This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmacologically active molecules. Its structure, featuring a tetrahydroisoquinoline core, is particularly valuable in the development of compounds targeting neurological disorders, such as Parkinson's disease and other neurodegenerative conditions. Additionally, it serves as a building block for the creation of potential therapeutics that interact with monoamine receptors, which are critical in regulating mood, cognition, and behavior. Its fluorine substitution enhances its metabolic stability and bioavailability, making it a preferred choice in drug discovery and optimization processes.